ShareThis Page

Newsmaker: Dr. Joel Schuman

| Friday, Sept. 21, 2012, 12:02 a.m.
Dr. Joel Schuman Noteworthy: Schuman is part of a multicenter and multidisciplinary team recognized by the Champalimaud Foundation in Lisbon, Portugal, for its invention and development over the past 20 years of optical coherence tomography, a noninvasive technology that produces a 3-D map of the eye and has become a standard part of eye care. The private organization, which supports biomedical research, awarded the team its 1 million euro ($1.3 million) Vision Award.
Dr. Joel Schuman Noteworthy: Schuman is part of a multicenter and multidisciplinary team recognized by the Champalimaud Foundation in Lisbon, Portugal, for its invention and development over the past 20 years of optical coherence tomography, a noninvasive technology that produces a 3-D map of the eye and has become a standard part of eye care. The private organization, which supports biomedical research, awarded the team its 1 million euro ($1.3 million) Vision Award.

Noteworthy: Schuman is part of a team recognized by the Champalimaud Foundation in Lisbon, Portugal, for its invention and development over the past 20 years of optical coherence tomography, a noninvasive technology that produces a 3-D map of the eye and has become a standard part of eye care. The foundation, which supports biomedical research, awarded the team its 1 million euro ($1.3 million) Vision Award.

Age: 53

Residence: Squirrel Hill

Family: Wife, Carole; daughter, Alexandra, 25; and sons, Eric, 23, and Ari, 19

Occupation: Chair of Ophthalmology at the University of Pittsburgh and director of UPMC's Eye Center

Background: Schuman completed an internship at Beth Israel Medical Center in New York City, a residency at the Medical College of Virginia and a fellowship at Harvard Medical School's Massachusetts Eye & Ear Infirmary. He heard about the eye mapping project while working on another experiment at Harvard.

Education: Bachelor of Arts degree from Columbia University and a medical degree from Mount Sinai School of Medicine in New York

Quote: "There's always a next step. We're trying to get the (eye mapping) device smaller, so we would be able to have it in a handheld instrument."

- Brian Bowling

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.